VIbes-Advanced Stem Cell Therapy PRP Treatment 12 Feb #39;14 - TV5 Hyderabad
By: Vibes Healthcare Ltd
Read more from the original source:
VIbes-Advanced Stem Cell Therapy & PRP Treatment 12 Feb'14 - TV5 Hyderabad - Video
Research Day 2014 Keynote - Orofacial Stem Cells: Tissue Regeneration and Beyond
Anh D. Le, DDS, PhD presents the annual Research Day keynote address. More information about this years #39; Research Day can be viewed at this link: http://dent...
By: UMichDent
Link:
Research Day 2014 Keynote - Orofacial Stem Cells: Tissue Regeneration and Beyond - Video
R3 Stem Cell Overview - Top Regenerative Medicine Clinics (844) GET-STEM
http://r3stemcell.com The top regenerative medicine clinics in the country are R3 Stem Cell Clinics. Stem Cell Therapy is offered for all musculoskeletal con...
By: R3 Stem Cell
See the rest here:
R3 Stem Cell Overview - Top Regenerative Medicine Clinics (844) GET-STEM - Video
VIbes-Advanced Stem Cell Therapy PRP Treatment 12 Feb #39;14 - TV5 Hyderabad
By: Vibes Healthcare Ltd
Visit link:
VIbes-Advanced Stem Cell Therapy & PRP Treatment 12 Feb'14 - TV5 Hyderabad - Video
Lekha Varun - Why they chose to preserve their baby #39;s stem cells
Lekha Varun, young parents from Chennai talk about why they thought it was important to preserve their baby #39;s stem cells. For further information on stem c...
By: Mylifecell
Read more:
Lekha & Varun - Why they chose to preserve their baby's stem cells - Video
UC Merced Anchor Cats: Inside The Lab (Stem Cells)
Anchor Cat Andrea Cho interviews Anley "T" Tefera, Graduate Researcher. *Produced By Students First Center in partnership with Media Cats For ALL Anchor Cats...
By: UC Merced Students First Center
The rest is here:
UC Merced Anchor Cats: Inside The Lab (Stem Cells) - Video
fat stem cells 2
http://www.arthritistreatmentcenter.com Stem Cells | What about fat? Farshid Guilak and colleagues published an article in the journal Biorheology. In it the...
By: Nathan Wei
Read more here:
fat stem cells 2 - Video
University of Washington researchers have created a line of human embryonic stem cells with the ability to develop into a far broader range of tissues than most existing cell lines.
"These cells will allow us to gain a much greater understanding of normal embryonic development and have the real potential for use in developing ways to grow new tissues and organs for transplantation," said Carol Ware, a professor of comparative medicine. She is the lead author of a paper describing the new cell line.
The findings are reported in the March 10 issue of the journal Proceedings of the National Academy of Sciences. The cells, called nave embryonic stem cells, normally appear at the earliest stages of embryonic development. They retain the ability to turn into any of all the different types of cells of the human body -- a capacity called "pluripotency."
Researchers had been able to develop nave cells using mouse embryonic stem cells, but to create naive human embryonic stem cells has required inserting a set of genes that force the cells to behave like naive cells.
While these transgenic cells are valuable research tools, the presence of artificially introduced genes meant the cells will not develop as normal embryonic cells would nor could they be safely used to create tissues and organs for transplantation.
In an article, Ware and her colleagues from the UW Institute for Stem Cell and Regenerative Medicine describe how they successfully created a line of nave human embryonic stem cells without introducing an artificial set of genes.
They first took embryonic stem cells that are slightly more developed, called primed stem cells, and grew them in a medium that contained factors that switched them back -- or "reverse toggled" them -- to the nave state. They then used the reverse toggled cells to develop a culture medium that would keep them in the nave state and create a stable cell line for study and research.
While the "reverse toggled" cells are much easier to create and will prove valuable research tools, Ware said, the cells that were directly derived from embryos are the more important advance because they are more likely to behave, grow and develop as embryonic cells do in nature.
The new cell line is called Elf1: "El" for the Ellison Foundation, a major supporter of the lab's work; "f" for female, the sex of the stem cell; and "1" for first.
Story Source:
Read more:
New cell line should accelerate embryonic stem cell research
Sweden Medical Forum, part 13 - Ms. Kristina Runeberg, Cellectis
Ms. Kristina Runeberg, Cellectis AB "Industrial platform for scale-up and differentiation of human pluripotent stem cells for Regerative Medicine" Find addit...
By: C0Orinir
Read more:
Sweden Medical Forum, part 13 - Ms. Kristina Runeberg, Cellectis - Video
Philadelphia, PA (PRWEB) March 13, 2014
Bioquark, Inc., (http://www.bioquark.com) a company focused on the development of combinatorial biologics for regeneration and disease reversion in human organs and tissues, today announces the appointment of Dr. Luis Martinez, MD, MPH, as VP of Global Operations.
We are honored to have someone with Dr. Martinezs experience join us as we execute on a globalized strategy in regenerative medicine, said Ira S. Pastor, CEO, Bioquark Inc. His broad clinical experience in applied regenerative medicine and cellular therapies make him a very valuable addition to the Bioquark team.
Dr. Martinez is a regenerative medicine and cell therapy specialist with over 10 years of experience in the clinical setting. He is currently the President of Elite Regenerative Medicine Group, a premier treatment and research center specializing in cell therapy applications for therapeutic, regenerative and preventive purposes. Dr. Martinez obtained his medical degree, as well as his Master of Public Health, at the Ponce School of Medicine and Health Sciences, and completed his residency at the prestigious University of Pennsylvania. He also completed a fellowship in biosecurity with the UPMC Center for Health Security. He is currently a clinical instructor at the Ponce School of Medicine and Health Sciences and is a board certified physician. Dr. Martinez also serves as vice-president of the XanoGene Anti-Aging Clinic and is President at Xyrion Medical, a biomedical consulting firm. He is a current consultant for multiple biomedical and pharmaceutical companies and conducts clinical research for various clients in the industry. Dr. Martinez is also a renowned international speaker, speaking at multiple venues for professional and academic organizations and he offers training to physicians in multiple applications of regenerative medicine, including Platelet Rich Plasma (PRP) therapy, adipose and bone marrow stem cell derived harvesting, preparation and therapeutic administration, as well as cytokine, growth factor and peptide therapies.
I am very excited about the biologic candidates being developed at Bioquark Inc. and their very novel approach to human regeneration and disease reversion, which has broad clinical applicability towards a range of degenerative disorders," said Dr. Martinez. "I'm pleased to be joining the team and am looking forward to playing a more active role in this truly transformational platform."
About Bioquark, Inc.
Bioquark Inc. is focused on the development of biologic based products that have the ability to alter the regulatory state of human tissues and organs, with the goal of curing a wide range of diseases, as well as effecting complex regeneration. Bioquark is developing biological pharmaceutical candidates, as well as products for the global consumer health and wellness market segments.
Sarasota, FL (PRWEB) March 12, 2014
Erectile dysfunction (ED) is the most commonly studied disorder when it comes to male sexual dysfunction. It is estimated that 18 million men in the US alone suffer from erectile dysfunction and that it appears to be affecting 1 in 4 males under age 40 according to a study published in The Journal of Sexual Medicine.
While the emphasis of treatments for ED focuses on relieving the symptoms, they only provide a temporary solution rather than a cure or reversing the cause.
The DaSilva Institute is excited to announce the recruitment of males suffering from ED, in an IRB study, which will look at the safety, and efficacy of autologous, adipose derived stem cells (ADSCs) in regenerating the causes of ED.
The evidence shows that ADSCs reverses the pathophysiological changes leading to ED, rather than treating the symptoms of ED. Not only is the data in the literature compelling, but our own, in-house, results on our patients have been phenomenal, states Dr. DaSilva.
The many underlying causes for ED that are being investigated range from those secondary to aging, to injury of the cavernous nerve secondary to injury, surgery and/or radiation of the prostate, to diabetic ED and Peyronies Disease to name a few. According to Dr. DaSilva, the possibilities for ADSCs in reversing ED are limitless.
Currently, there is an expansive and growing body of evidence in the medical literature strongly indicating that ADSCs might be a potential cure for ED, rather than merely symptom relief, which is indicative of the increasing interest in ADSC-regenerative options for sexual medicine over the past decade. The DaSilva Institutes goal is to take this from pre-clinical studies to the clinical world offering it to all males that suffer from intractable ED under an IRB approved protocol.
More information about Dr. DaSilva and the DaSilva Institute Guy DaSilva, MD is currently the medical director of the DaSilva Institute of Anti-Aging, Regenerative & Functional Medicine, located in Sarasota, Florida. Dr. DaSilvas enthusiasm for using autologous stem cells in regenerative medicine comes from his early days as a pathologist in New York City back in 1987 and later as a fellow in hematology in1990 following his residency in internal medicine.
He later brought his expertise in molecular and cellular medicine to the University of Kansas Medical Center where he served as chief of Hematology & Hematopathology. He later became the CEO and medical director of HemePath Institute, a diagnostic leader in diagnosing the most difficult cases of leukemia and lymphomas. Most recently, Dr. DaSilva teamed up with one of the most influential stem cell scientist in the world to bring the highest quality and viability of the harvested stem cells, bar none, to the DaSilva Institute.
Dr. DaSilva is board certified and fellowship trained in Anti-Aging and Regenerative Medicine. For more information about Dr. DaSilva or the DaSilva Institute go to http://www.dasilvainstitute.com.
Go here to see the original:
DaSilva Institute of Anti-Aging, Regenerative & Functional Medicine Offers Autologous Stem Cell Therapy for Men ...
Boca Raton, Florida (PRWEB) March 12, 2014
The Miami Stem Cell Treatment Center, PC, located in Miami, Ft. Lauderdale, and Boca Raton, Florida, offers a free public seminar on the use of stem cells for various degenerative and inflammatory conditions. They will be provided by Dr. Thomas A. Gionis, Surgeon-in-Chief, and, Dr. Nia Smyrniotis, Medical Director. The next upcoming seminar will be held on March 16th at the Comfort Suites Weston, 2201 N. Commerce Parkway, Weston, Florida 33326, at 2pm.
Regenerative Medicine: Our Procedure The Miami Stem Cell Treatment Center uses Autologous Adult Adipose Stem Cells to provide care for patients suffering from chronic conditions that may benefit from adult stem cell-based regenerative medicine.
The Miami Stem Cell Treatment Center follows the regenerative medicine procedures developed by the California Stem Cell Treatment Centers (CSCTC) and Cell Surgical Network (CSN) which involves the initial screening, examination and evaluation of every potential candidate for stem cell investigational therapy by one of our physicians. Once a patient is deemed to be an appropriate candidate, the procedure itself is performed by our Surgeon-in-Chief, who is assisted by a team of experienced surgical team members and surgical technicians. The entire process from start to finish takes less than two hours. It is relatively painless, and recovery time is minimal.
In recent times, the bone marrow has been a source for stem cells. Taking bone marrow, however, is a painful procedure. Fat, however, contains many times more stem cells than bone marrow and is much easier and safer to harvest.
For many disease types such as cardiac pathology, adipose derived cells appear to be showing superiority to bone marrow derived cells. This may be related to the well documented fact that chronic disease causes bone marrow suppression. Fat derived cells are a natural choice for our investigational work considering their easy and rapid availability in extremely high numbers.
With our current technology, we can harvest your own fat cells, digest the fat cells and separate out the stem cells. The most significant advantage of using your fat as a source for the stem cells, is that the procedure can be done in the office in only a few hours, as the stem cells can be ready for injection after only 60 minutes of processing with our state of the art equipment. Your stem cells do NOT need to be sent out for processing and there is no need for you to travel outside of the U.S. to have them injected.
Indeed, adipose tissue is an abundant source of mesenchymal stem cells, which have shown promise in the field of regenerative medicine. Furthermore, these cells can be readily harvested in large numbers with low donor-site morbidity. During the past decade, numerous studies have provided pre-clinical data on the safety and efficacy of adipose-derived stem cells, supporting the use of these cells in clinical applications. Various clinical trials have shown the regenerative capability of adipose-derived stem cells in numerous fields of medicine. In addition, a great deal of knowledge concerning the harvesting, characterization, and culture of adipose-derived stem cells has been reported.
Our current areas of study include: Heart Failure, Emphysema, COPD, Asthma, Parkinsons Disease, Stroke, Multiple Sclerosis, and orthopedic joint injections. . The investigational protocols utilized by the Miami Stem Cell Treatment Center have been reviewed and approved by an IRB (Institutional Review Board) which is registered with the U.S. Department of Research Protections; and the study is registered with http://www.Clinicaltrials.gov, a service of the U.S. National Institutes of Health (NIH). For more information contact: Miami(at)MiamiStemCellsUSA(dot)com or visit our website: http://www.MiamiStemCellsUSA.com.
See the article here:
Miami Stem Cell Treatment Center: What The Stem Cell Procedure Entails and An Invitation To MSCTC Public Seminar; Meet ...
Contact Information
Available for logged-in reporters only
Newswise COLUMBUS, Ohio -- Imagine a world where malfunctioning organs are replaced by new ones made from your own tissues, where infected wounds are cured with a signal from your smartphone, where doctors find the perfect medicine for whatever ails you simply by studying your stem cells.
Its a world thats inching closer to reality because of the work of some of the nations top scientists, many of whom will gather March 13-15 at The Ohio State University for the 7th Annual Translational to Clinical (T2C) Regenerative Medicine Conference to discuss their recent successes and challenges in coaxing the body to heal itself in extraordinary ways.
Regenerative medicine will change the way you and I experience sickness, health and healthcare, said Chandan Sen, director of the Center for Regenerative Medicine and Cell Based Therapies at Ohio States Wexner Medical Center. Because the field is so new, we as researchers are also changing the way we work to be synergistic not competitive, so patients are able to access the benefits more quickly.
And the benefits are desperately needed, says keynote speaker Dr. Anthony Atala, director of the Wake Forest Institute for Regenerative Medicine at Wake Forest Baptist Medical Center.
From chronic diseases such as kidney failure that costs billions of dollars each year to the medical needs of our aging population and the significant injuries sustained by military troops in Afghanistan, developing new treatment paradigms is essential, said Atala, who was selected to lead the $75 million Armed Forces Institute of Regenerative Medicine (AFIRM), a consortium of 30 academic and industry partners in applying regenerative medicine techniques to battlefield injuries.
In theory, every tissue in the body has the ability to regenerate and heal itself. Its good to come to this meeting and exchange ideas that will enable us to harness that remarkable ability.
Other speakers include Elaine Fuchs, Howard Hughes Medical Institute investigator and Rebecca C. Lancefield Professor at Rockefeller University in New York, who has advanced multiple areas of stem cell research through her work in skin cells and genetics; and Dr. Michael Longaker, director of the Hagey Laboratory for Stem Cell Biology for Pediatric Regenerative Medicine at Stanford University. Longaker is considered one of the nations experts in using a combination of stem cell- and bioengineering-based technologies for craniofacial reconstruction.
Several Ohio State College of Medicine and Wexner Medical Center clinician-scientists are also sharing research updates during pre-conference lectures and the meeting:
See the article here:
Advances in Stem Cell, Organ Printing, Tissue Engineering Changing Healthcare, Saving Lives
Hutchins Society: #39;Renal Failure Stem Cells #39;
Courtesy of WCGS Photographers #39; Society *******************************************************
By: WCGS Photographers #39; Society
Link:
Hutchins Society: 'Renal Failure & Stem Cells' - Video
Stem Cell | Skeletal muscle source of stem cells
Skeletal muscle stem cells... another alternative? Matsumoto and colleagues, in an article published in Arthritis and Rheumatism, looked at a rat model of os...
By: Nathan Wei
Read this article:
Stem Cell | Skeletal muscle source of stem cells - Video
By Maggie Fox
One of the worlds leading stem cell experts has suggested withdrawing a study that made global headlines last January, saying he has questions about some of the images and data in it.
The Japanese team, led by Teruhiko Wakayama, reported that they had created powerful stem cells by doing little more than soaking ordinary cells in an acid solution.
The report, published in the journal Nature, impressed other stem cell researchers and opened the possibility of an easy approach to regenerative medicine. But Japanese television quotes Wakayama as saying he wants to take a closer look.
"When conducting the experiment, I believed it was absolutely right, Reuters news agency quotes Wakayama as telling the television station NHK.
"But now that many mistakes have emerged, I think it is best to withdraw the research paper once and, using correct data and correct pictures, to prove once again the paper is right," he said.
"If it turns out to be wrong, we would need to make it clear why a thing like this happened."
But Charles Vacanti of Harvard Medical School and Brigham and Women's Hospital in Boston, who helped work on the study, said he disagreed. "Some mistakes were made, but they don't affect the conclusions," the Wall Street Journal quoted him as saying.
"Based on the information I have, I see no reason why these papers should be retracted."
Stem cell researchers may be more sensitive than other scientists. In 2006, Seoul National University fired Hwang Woo-Suk after the journal Science retracted two papers he wrote claiming to have cloned human embryos and extracted stem cells from them.
More here:
Stem Cell Researcher Suggests Recalling His Own Study
Adult Stem Cells- A Medical Revolution in the Making
Our bodies are made and rejuvenated by stem cells. Join us to learn about the latest advances in adult stem cell cell technology and how they will truly tran...
By: Notre Dame Science
Visit link:
Adult Stem Cells- A Medical Revolution in the Making - Video
11 WebOps 1
This company provides a service whereby stem cell biopsies can be stored fresh from the operating table in a specially deigned canister which maintains an in...
By: Global Alliance for Regenerative Medicine, Roatan, Honduras
Read the original here:
11 WebOps 1 - Video
Seven months after a bill to create a regional stem cell therapy hub at the University of Kansas Medical Center took effect, two doctors from the center say it is enrolling patients in clinical trials and they are beginning their work.
David Prentice and Buddhadeb Dawn expressed excitement Monday about what the Midwest Stem Cell Therapy Center has been able to accomplish in a short time and what possibilities it holds for the future.
"Kansas can be the leader in providing adult stem cell treatments and information to physicians and patients around the world," Dawn said.
Prentice said the center, which limits itself to research on adult stem cells, will foster "ethical, non-controversial" treatments for patients with multiple sclerosis, spinal cord injuries, heart damage, stroke and juvenile diabetes.
At the same time he said it will serve to educate schoolchildren on the promise of adult stem cells and act as a "hub" for regional research.
Potentially physicians from across the region could be sending samples," Prentice told the Senate Ways and Means Committee that approved millions in start-up funds for the center last year.
Sen. Jeff Melcher, R-Leawood, said he was heartened by news of the center beginning work, but somewhat concerned about it monetizing that work.
He noted that the 15 members of the center's advisory board are academics and legislators, with no one from the business community.
I see kind of a void in that I dont see the people that it would take to product-ize this," Melcher said. "The sales and marketing expertise, the product development.
Dawn said the medical center has some "in-house" experts who can help with that and that it will also be working with specific companies in some of its clinical trials.
Read the original post:
Stem cell center starting trials
Topeka Eight months after the establishment of the Midwest Stem Cell Therapy Center at Kansas University Medical Center, the center is conducting clinical trials and advancing treatments for numerous diseases, KU officials said Monday.
"We are very excited about the work that is going on," said Dr. Doug Girod, executive vice chancellor of the KU Medical Center.
Dr. Buddhadeb Dawn, the center's director, detailed clinical trials that are under way and several in the planning stages to the Senate Ways and Means Committee.
"These trials will help local patients to get access to stem cell therapy," Dawn said. "Kansas can be a leader in providing stem cell treatments."
Created last year by the Legislature and Gov. Sam Brownback, the center will work on adult stem cell, cord blood and related stem cell research, providing therapies to patients and serving as a clearinghouse for physicians on cutting-edge treatments.
The center is prohibited from using embryonic stem cells or cells taken from aborted fetal tissue. Abortion opponents oppose human embryonic stem cell research because it involves the destruction of the embryo.
David Prentice, senior fellow for life sciences of the Family Research Council, said the center was unique in the country.
Prentice, who was involved in the development of the center and is on the center's advisory board as a representative of the scientific community, said, "I do want to reemphasize the focus on the center is patient-centered," while also working on education, clinical trials and research.
The FRC describes itself as a Christian organization promoting the traditional family unit and the Judeo-Christian value system. Its critics say it spreads anti-gay propaganda.
State Sen. Jeff Melcher, R-Overland Park, said the research sounded exciting but that he was concerned that the advisory board had no business people on it to secure private and business funding.
Originally posted here:
Stem Cell Center advancing treatments, officials say